Literature DB >> 30029904

Deletion of PPARγ in lung macrophages provides an immunoprotective response against M. tuberculosis infection in mice.

Evelyn Guirado1, Murugesan Vs Rajaram2, Ajay Chawla3, Joanna Daigle4, Krista Md La Perle5, Eusondia Arnett6, Joanne Turner7, Larry S Schlesinger8.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear transcription factor belonging to the superfamily of ligand-activated nuclear receptors. It is activated by diverse endogenous lipid metabolites as well as by exogenous ligands such as the thiazolidinediones. It regulates cellular metabolism, proliferation, differentiation, and inflammation, the latter in part through trans-repression of pro-inflammatory cytokines. PPARγ is highly expressed in alternatively activated alveolar macrophages (AMs), a primary host cell for airborne Mycobacterium tuberculosis (M.tb). Our previous in vitro study identified the importance of PPARγ activation through the mannose receptor (CD206) on human macrophages in enabling M. tb growth. The aim of the current study was to investigate the role of PPARγ in vivo during M. tb infection using a macrophage-specific PPARγ knock out mouse model with special emphasis on the lung environment. Our data show that the absence of PPARγ in lung macrophages reduces the growth of virulent M. tb, enhances pro-inflammatory cytokines and reduces granulomatous infiltration. These findings demonstrate that PPARγ activation, which down-regulates macrophage pro-inflammatory responses, impacts the lung's response to M. tb infection, thereby supporting PPARγ's role in tuberculosis (TB) pathogenesis.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  M. tuberculosis; Macrophage; PPARγ

Mesh:

Substances:

Year:  2018        PMID: 30029904      PMCID: PMC6481684          DOI: 10.1016/j.tube.2018.06.012

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  39 in total

Review 1.  The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function.

Authors:  M Ricote; J T Huang; J S Welch; C K Glass
Journal:  J Leukoc Biol       Date:  1999-11       Impact factor: 4.962

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Gallium disrupts iron metabolism of mycobacteria residing within human macrophages.

Authors:  O Olakanmi; B E Britigan; L S Schlesinger
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice.

Authors:  Evelyn Guirado; Isabel Amat; Olga Gil; Jorge Díaz; Virginia Arcos; Neus Caceres; Vicenç Ausina; Pere-Joan Cardona
Journal:  Microbes Infect       Date:  2006-01-27       Impact factor: 2.700

5.  Th1 cytokines facilitate CD8-T-cell-mediated early resistance to infection with Mycobacterium tuberculosis in old mice.

Authors:  Bridget Vesosky; David K Flaherty; Joanne Turner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

7.  Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages.

Authors:  Kazuhiro Asada; Shigekazu Sasaki; Takafumi Suda; Kingo Chida; Hirotoshi Nakamura
Journal:  Am J Respir Crit Care Med       Date:  2003-10-16       Impact factor: 21.405

8.  Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.

Authors:  Antje Kahnert; Peter Seiler; Maik Stein; Silke Bandermann; Karin Hahnke; Hans Mollenkopf; Stefan H E Kaufmann
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

9.  Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands.

Authors:  Raju C Reddy; Venkateshwar G Keshamouni; Shamsul H Jaigirdar; Xianying Zeng; Todd Leff; Victor J Thannickal; Theodore J Standiford
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-11-14       Impact factor: 5.464

10.  Activation of peroxisome proliferator-activated receptor gamma by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst.

Authors:  Andreas Von Knethen; Bernhard Brüne
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  16 in total

1.  l-Arginine Synthesis from l-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo.

Authors:  Shannon M Lange; Melanie C McKell; Stephanie M Schmidt; Junfang Zhao; Rebecca R Crowther; Lisa C Green; Rebecca L Bricker; Eusondia Arnett; S Eleonore Köhler; Larry S Schlesinger; Kenneth D R Setchell; Joseph E Qualls
Journal:  J Immunol       Date:  2019-02-01       Impact factor: 5.422

Review 2.  Immunometabolism at the interface between macrophages and pathogens.

Authors:  David G Russell; Lu Huang; Brian C VanderVen
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

Review 3.  Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know.

Authors:  Chrissy M Leopold Wager; Eusondia Arnett; Larry S Schlesinger
Journal:  Tuberculosis (Edinb)       Date:  2019-04-25       Impact factor: 3.131

Review 4.  The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections.

Authors:  Jordi B Torrelles; Blanca I Restrepo; Yidong Bai; Corinna Ross; Larry S Schlesinger; Joanne Turner
Journal:  Front Aging       Date:  2022-01-19

Review 5.  Surveying the Epigenetic Landscape of Tuberculosis in Alveolar Macrophages.

Authors:  Yi Chu Liang; Nusrah Rajabalee; Katrina Madden; Gonzalo G Alvarez; Jim Sun
Journal:  Infect Immun       Date:  2022-03-21       Impact factor: 3.609

6.  α-Glucosidase Inhibitor Can Effectively Inhibit the Risk of Tuberculosis in Patients with Diabetes: A Nested Case-Control Study.

Authors:  Kai-Huang Lin; Ci-Wen Luo; Shih-Pin Chen; Dom-Gene Tu; Ming-Shian Lin; Yu-Hsiang Kuan
Journal:  Biomed Res Int       Date:  2020-05-19       Impact factor: 3.411

Review 7.  Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development.

Authors:  Ailin Yang; Yanjun Wu; Ganggang Yu; Haoyan Wang
Journal:  Respir Res       Date:  2021-07-14

Review 8.  An Army Marches on Its Stomach: Metabolic Intermediates as Antimicrobial Mediators in Mycobacterium tuberculosis Infection.

Authors:  Emer E Hackett; Frederick J Sheedy
Journal:  Front Cell Infect Microbiol       Date:  2020-08-25       Impact factor: 5.293

Review 9.  Targeting immunometabolism in host defence against Mycobacterium tuberculosis.

Authors:  Frederick J Sheedy; Maziar Divangahi
Journal:  Immunology       Date:  2020-10-28       Impact factor: 7.397

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.